| 10399920 |
Crystalline form of cannabidiol |
Daniel Levin |
2019-09-03 |
|
| 10053407 |
Crystalline cannabidivarin |
Emerich Eisenreich, Daniel Levin, Mackenzie Marrs |
2018-08-21 |
|
| 9181280 |
Factor VIIa inhibitor |
Dange Vijay Kumar, Colin O'Bryan, Roopa Rai, William D. Shrader |
2015-11-10 |
|
| 8796451 |
Crystalline pharmaceutical |
Sanjay R. Chemburkar, James J. Fort, Rodger F. Henry, David Lechuga-Ballesteros, Yuping Niu +1 more |
2014-08-05 |
$63,281,000 |
| 8729117 |
Factor VIIa inhibitor |
Dange Vijay Kumar, Colin O'Bryan, Roopa Rai, William D. Shrader |
2014-05-20 |
$81,948,000 |
| 8426415 |
Human ADAM-10 inhibitors |
Sriram Naganathan, JoAnn Wilson |
2013-04-23 |
|
| 8415328 |
Factor VIIa inhibitor |
Dange Vijay Kumar, Colin O'Bryan, Roopa Rai, William D. Shrader, Kieron E. Wesson |
2013-04-09 |
$59,434,000 |
| 8058433 |
Crystalline pharmaceutical |
Sanjay R. Chemburkar, James J. Fort, Rodger F. Henry, David Lechuga-Ballesteros, Yuping Niu +1 more |
2011-11-15 |
$24,545,000 |
| 7989656 |
Biaryl carboxylic acid apoptosis promoters |
Michael D. Wendt, Hong Ding, Sheela A. Thomas, Steven W. Elmore, Wang Shen +1 more |
2011-08-02 |
$102,514,000 |
| 7968707 |
Retroviral protease inhibiting compounds |
Hing L. Sham, Daniel W. Norbeck, Xiaoqi Chen, David A. Betebenner, Dale J. Kempf +13 more |
2011-06-28 |
$33,532,000 |
| 7754886 |
N-acylsulfonamide apoptosis promoters |
David J. Augeri, Steven A. Baumeister, Milan Bruncko, Hong Ding, Jurgen Dinges +12 more |
2010-07-13 |
$40,351,000 |
| 7750004 |
Apoptosis promoters |
Michael D. Wendt, Hong Ding, Sheela A. Thomas, Steven W. Elmore, Wang Shen +1 more |
2010-07-06 |
$51,963,000 |
| 7504512 |
N-acylsulfonamide apoptosis promoters |
David J. Augeri, Steven A. Baumeister, Milan Bruncko, Hong Ding, Jurgen Dinges +12 more |
2009-03-17 |
$109,246,000 |
| 7279582 |
Retroviral protease inhibiting compounds |
Eric J. Stoner, Arthur J. Cooper, Lawrence Kolaczkowski, Ketan M. Patel, Hing L. Sham +8 more |
2007-10-09 |
$100,410,000 |
| 6864369 |
Crystalline pharmaceutical |
Sanjay R. Chemburkar, James J. Fort, Rodger F. Henry, David Lechuga-Ballesteros, Yuping Niu +1 more |
2005-03-08 |
$60,295,000 |
| 6720338 |
N-acylsulfonamide apoptosis promoters |
David J. Augeri, Steven A. Baumeister, Milan Bruncko, Hong Ding, Jurgen Dinges +12 more |
2004-04-13 |
$74,796,000 |
| 6608198 |
Crystalline pharmaceutical |
Sanjay R. Chemburkar, James J. Fort, Rodger F. Henry, David Lechuga-Ballesteros, Yuping Niu +1 more |
2003-08-19 |
$90,628,000 |
| 6472529 |
Retroviral protease inhibiting compounds |
Hing L. Sham, Daniel W. Norbeck, Xiaoqi Chen, David A. Betebenner, Dale J. Kempf +13 more |
2002-10-29 |
$69,103,000 |
| 6313296 |
Retroviral protease inhibiting compounds |
Hing L. Sham, Daniel W. Norbeck, Xiaoqi Chen, David A. Betebenner, Dale J. Kempf +13 more |
2001-11-06 |
$138,125,000 |
| 5580989 |
Process for the preparation of N-4-[(substituted phenyl)alkylheterocyclic]- N |
James D. Ratajczyk, Juliette K. Busse, Sanjay R. Chemburkar, Yi-Yin Ku, Hemantkumar H. Patel +5 more |
1996-12-03 |
$40,005,000 |
| 5275950 |
Process for the preparation of a renin inhibiting compound |
Bruce W. Horrom, Chi-Nung Hsiao, M. Robert Leanna, Hormoz Mazdiyasni, Howard E. Morton +3 more |
1994-01-04 |
$61,950,000 |
| 5169961 |
Process for the production of 2-acetylbenzo [.beta.]thiophenes |
Bruce W. Horrom, Brian A. Roden, Sanjay R. Chemburkar |
1992-12-08 |
$51,434,000 |
